Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1995-06-07
1997-02-04
Fleisher, Mindy
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
4352351, A61K 39265, C12N 701
Patent
active
055995446
ABSTRACT:
The present invention provides recombinant infectious bovine rhinotracheitis (IBR) viruses useful in vaccines to protect bovines from infectious bovine rhinotracheitis and other bovine diseases. The present invention further provides methods for distinguishing an animal vaccinated with the vaccine of the present invention from an animal infected with a naturally-occurring IBR virus. The present invention also provides isolated DNA encoding the gpE glycoprotein of IBR virus and isolated DNA encoding the gpG glycoprotein of IBR virus.
REFERENCES:
patent: 4992051 (1991-02-01), Kit et al.
Cochran Mark D.
MacDonald Richard D.
Fleisher Mindy
McKelvey Terry A.
PruTech Research and Development Partnership
Syntro Corporation
White John P.
LandOfFree
Recombinant infectious bovine rhinotracheitis virus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant infectious bovine rhinotracheitis virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant infectious bovine rhinotracheitis virus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-676138